International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(12), P. 6730 - 6730
Published: June 19, 2024
Renal
cell
carcinoma
(RCC)
is
a
significant
oncological
challenge
due
to
its
heterogeneous
nature
and
limited
treatment
options.
The
PAX
developmental
gene
family
encodes
nine
highly
conserved
transcription
factors
that
play
crucial
roles
in
embryonic
development
organogenesis,
which
have
been
implicated
the
occurrence
of
RCC.
This
review
explores
molecular
landscape
RCC,
with
specific
focus
on
role
RCC
tumorigenesis
disease
progression.
Of
various
subtypes,
clear
renal
(ccRCC)
most
prevalent,
characterized
by
loss
von
Hippel–Lindau
(VHL)
tumor
suppressor
gene.
Here,
we
published
literature
expression
patterns
functional
implications
genes,
particularly
PAX2
PAX8,
three
common
including
ccRCC,
papillary
(PRCC),
chromophobe
(ChRCC).
Further,
interactions
potential
biological
mechanisms
involving
genes
VHL
driving
pathogenesis
key
signaling
pathways
mediated
ccRCC
associated
implicating
PAX.
Lastly,
concurrent
our
update
regarding
research
comment
targeting
towards
novel
therapies.
Abstract
Hypoxia-inducible
factors
(HIFs)
are
essential
transcription
that
orchestrate
cellular
responses
to
oxygen
deprivation.
HIF-1α,
as
an
unstable
subunit
of
HIF-1,
is
usually
hydroxylated
by
prolyl
hydroxylase
domain
enzymes
under
normoxic
conditions,
leading
ubiquitination
and
proteasomal
degradation,
thereby
keeping
low
levels.
Instead
hypoxia,
sometimes
even
in
normoxia,
HIF-1α
translocates
into
the
nucleus,
dimerizes
with
HIF-1β
generate
then
activates
genes
involved
adaptive
such
angiogenesis,
metabolic
reprogramming,
survival,
which
presents
new
challenges
insights
its
role
processes.
Thus,
review
delves
mechanisms
HIF-1
maintains
stability
normoxia
including
but
not
limited
giving
transcriptional,
translational,
well
posttranslational
regulation
underscore
pivotal
adaptation
malignancy.
Moreover,
extensively
cancer
cardiovascular
diseases
potentially
serves
a
bridge
between
them.
An
overview
HIF-1-related
drugs
approved
or
clinical
trials
summarized,
highlighting
their
potential
capacity
for
targeting
toxicity
related
treatment.
The
provides
comprehensive
insight
HIF-1’s
regulatory
mechanism
paves
way
future
research
therapeutic
development.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(1), P. 70 - 70
Published: Jan. 7, 2025
Malignant
growth
is
expected
to
surpass
other
significant
causes
of
death
as
one
the
top
reasons
for
dismalness
and
mortality
worldwide.
According
a
World
Health
Organization
(WHO)
study,
this
illness
approximately
between
9
10
million
instances
deaths
annually.
Chemotherapy,
radiation,
surgery
are
three
main
methods
treating
cancer.
These
seek
completely
eradicate
all
cancer
cells
while
having
fewest
possible
unintended
impacts
on
healthy
cell
types.
Owing
lack
target
selectivity,
majority
medications
have
substantial
side
effects.
On
hand,
nanomaterials
transformed
identification,
diagnosis,
management
Nanostructures
with
biomimetic
properties
been
grown
late,
fully
intent
observing
sickness.
nanostructures
be
consumed
by
in
areas
profound
disease.
Furthermore,
because
their
extraordinary
physicochemical
properties,
which
incorporate
nanoscale
aspects,
more
prominent
surface
region,
explicit
geometrical
features,
ability
embody
different
substances
within
or
outside
surfaces,
remarkable
nano-vehicles
conveying
restorative
specialists
designated
regions.
This
review
discusses
recent
developments
nanostructured
materials
such
graphene,
dendrimers,
cell-penetrating
peptide
nanoparticles,
nanoliposomes,
lipid
magnetic
nano-omics
diagnosis
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 9, 2025
Clear
cell
renal
carcinoma
(ccRCC)
is
resistant
to
radiotherapy
and
chemotherapy.
Thus,
it
necessary
find
new
diagnostic
markers
therapeutic
targets
increase
the
overall
outcomes
of
ccRCC.
Recent
studies
have
shown
that
methods
interfere
with
energy
transfer
system
can
also
positively
affect
treatment
process.
The
present
study
focused
on
finding
associated
mitochondrial
metabolic
pathways
outcome
For
this
purpose,
we
investigated
various
aspects
relationship
between
metabolism
ccRCC
based
analysis
gene
network
connections
differentially
expressed
genes,
through
assessment
protein–protein
interaction,
mutations,
promoter
methylation
related
genes.
We
interaction
miRNAs
immune
infiltration
analysis.
Through
these
steps,
provided
a
list
possible
for
current
further
proved
importance
in
pathogenesis
from
be
used
Mini-invasive Surgery,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 20, 2025
Partial
nephrectomy
(PN)
has
become
the
standard
of
treatment
for
most
T1
renal
masses
and
is
suitable
selected
T2
cortical
masses.
In
this
setting,
management
complex
(CRM)
requires
a
thorough
understanding
potential
risks
benefits
both
PN
radical
(RN).
Indeed,
thanks
to
advent
robotic
surgery,
indications
have
expanded
include
larger
tumors
CRM,
despite
associated
surgical
complexity
oncologic
risks.
The
decision-making
process
CRM
with
or
RN
complex.
Thus,
current
review
aims
explore
essentials
patients
identify
research
gaps,
address
clinical
challenge
determining
approach.
Current
evidence
suggests
that
while
offers
clear
advantage
in
tissue
preservation,
it
may
carry
higher
perioperative
compared
RN.
However,
these
should
be
balanced
long-term
function
preservation.
conclusion,
further
high-quality,
prospective
studies
are
needed
better
define
comparative
effectiveness
vs
.
guide
CRM.
Journal of Cancer Metastasis and Treatment,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 21, 2025
Aim:
In
cancer
tissues,
glycolysis
metabolism
is
often
heightened,
making
18F-fluorodeoxyglucose
positron
emission
tomography/computed
tomography
(FDG-PET/CT)
useful
for
assessing
glucose
metabolism.
However,
the
kidneys'
high
makes
it
difficult
to
distinguish
between
normal
renal
tissue
and
cancer.
This
study
aims
evaluate
maximum
standardized
uptake
value
(SUVmax)
in
using
PET/CT
determine
its
relationship
prognosis.
Methods:
We
also
aim
examine
correlation
SUVmax
clinical
parameters
potential
link
enrolled
105
patients
who
underwent
FDG-PET/CT
March
2012
October
2017.
These
patients,
diagnosed
with
localized
cell
carcinoma
(RCC),
surgery
were
pathologically
confirmed
have
clear
RCC
(ccRCC).
investigated
impact
of
other
on
recurrence.
Results:
C-reactive
protein
(CRP)
associated
tumor
progression,
alongside
stage,
nuclear
grade,
microvascular
invasion
[v(+)],
tumor-infiltrating
lymphocytes
(TILs).
Multivariate
analysis
recurrence-free
survival
(RFS)
as
endpoint
indicated
significant
results
(SUVmax
≥
3.7:
relative
risk
8.98,
P
<
0.01;
CRP
0.11
mg/dL:
6.03,
0.01,
n
=
89).
curve
RFS,
or
elevated
predicted
poor
prognosis,
further
worsening
when
v(+)
was
added.
Conclusion:
a
strong
prognostic
factor
outcomes.
factor,
though
should
be
interpreted
cautiously,
reflects
overall
systemic
conditions
may
not
exclusively
represent
activity.
Further
research
into
pre-treatment
prognosis
prediction
anticipated.
Journal of Multidisciplinary Healthcare,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 421 - 433
Published: Jan. 1, 2025
This
study
aimed
to
explore
the
value
of
a
radiomic
nomogram
based
on
contrast-enhanced
computed
tomography
(CECT)
for
differentiating
benign
and
malignant
solid-containing
renal
masses.
A
total
122
patients
with
pathologically
confirmed
(n=47)
or
(n=75)
masses
were
enrolled
in
this
study.
Radiomic
features
extracted
from
arterial,
venous
delayed
phases
further
analysed
by
dimensionality
reduction
selection.
Four
mainstream
machine
learning
algorithm
training
models,
namely,
support
vector
(SVM),
k-nearest
neighbour
(kNN),
light
gradient
boosting
(LightGBM)
logistic
regression
(LR),
constructed
determine
best
classifier
model.
Univariate
multivariate
analyses
used
clinical
characteristics
constructing
The
signatures
integrated
construct
combined
Receiver
operating
characteristic
(ROC)
curves
area
under
curve
(AUC)
evaluate
performance
nomogram,
signature,
Thirteen
selected
development
signature.
Among
various
LR
model
demonstrated
superior
predictive
efficiency
robustness,
yielding
an
AUC
0.952
cohort
0.887
test
cohort.
was
0.854
0.747
Furthermore,
which
incorporated
sex,
age,
alcohol
consumption
history,
exhibited
excellent
discriminative
performance,
0.973
0.900
CECT
offers
promising
noninvasive
approach
distinguishing
solid
tool
can
be
guide
treatment
strategies
effectively
provide
valuable
insights
clinicians.